As of 2025-07-19, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 12.3x | 12.0x |
| Forward P/E multiples | 11.6x - 19.6x | 17.0x |
| Fair Price | (99.17) - (102.60) | (113.14) |
| Upside | -7445.6% - -7699.9% | -8480.9% |
| Date | EV/EBITDA |